| Members |
targetComponentId |
| Special care of gastrointestinal tube patient |
Attention to gastrointestinal tract tube |
| Special care of immunosuppressed patient |
Care of immunosuppressed patient (regime/therapy) |
| Special care of patient in delivery room |
Delivery room care (regime/therapy) |
| Special care of patient in operating room |
Intraoperative care (regime/therapy) |
| Special care of patient with contagious disease |
Care of patient with infectious disease (regime/therapy) |
| Special care of patient with seizures |
Seizure precautions |
| Special endoscopic procedures |
intervention endoscopique |
| Special nursing care in intensive care unit |
Care of intensive care unit patient (regime/therapy) |
| Special nursing care of burned patient |
Burn care (regime/therapy) |
| Special nursing care of unconscious patient (procedure) |
Care of unconscious patient (regime/therapy) |
| Special nursing procedure |
Nursing procedure |
| Special plain X-ray investigations of head (procedure) |
Plain film of body region |
| Special postmortem body preparation |
Postmortem care (regime/therapy) |
| Special postpartum nursing care (procedure) |
Postpartum care (regime/therapy) |
| Special ward care nursing procedure |
Nursing procedure |
| Specific antibody |
Antibody |
| Specific contrast radiology procedures (procedure) |
Diagnostic radiography with contrast media |
| Specific nuclear medicine studies |
Nuclear medicine procedure (procedure) |
| Specific or special nursing care (procedure) |
Nursing procedure |
| Specified complication following molar or ectopic pregnancy, NEC |
Complication following molar AND/OR ectopic pregnancy |
| Specified perinatal disorder of digestive system, NEC |
troubles de l'appareil digestif spécifiques du fœtus ou du nouveau-né |
| Spectinomycin 2g powder for injection solution vial (product) |
Product containing precisely spectinomycin hydrochloride 400 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Spectinomycin hydrochloride 2g powder (product) |
Product containing precisely spectinomycin hydrochloride 400 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Spermatocytogenesis |
Spermatogenesis, function (observable entity) |
| Sphingobacterium mizutae (organism) |
Sphingobacterium mizutaii (organism) |
| Spinal nerve root C0 |
Spinal nerve root C1 |
| Spinal stenosis of other region, NEC |
Spinal stenosis |
| Spirochetal infection, NEC |
infection spirochétienne |
| Spiroptera |
Gongylonema (organisme) |
| Splenomegaly co-occurrent and due to storage disease (disorder) |
Enlargement of spleen due to storage disease (disorder) |
| pose d'une endoprothèse urétérale |
insertion d'un stent dans l'uretère |
| Spongioblastoma (morphologic abnormality) |
Pilocytic astrocytoma |
| Spontaneous abortion with specified complication, NEC |
Miscarriage with complication |
| Spontaneous ocular nystagmus (disorder) |
Visual deprivation nystagmus |
| Spontaneous rupture of fetal membranes |
Spontaneous rupture of fetal membranes |
| Spontaneous rupture of membranes |
Spontaneous rupture of fetal membranes |
| Sporosarcina globisporus subspecies globisporus (organism) |
Sporosarcina globispora (organism) |
| Sporosarcina urea |
Sporosarcina ureae (organism) |
| Sports injury |
Injury while engaged in sports activity (disorder) |
| Sprain AND/OR strain of sacroiliac region (disorder) |
Sprain of sacroiliac region |
| Sprain finger, carpometacarpal joint |
Sprain of metacarpophalangeal joint |
| Sprain of costal cartilage (disorder) |
Chondrocostal joint sprain |
| entorse du cartilage costal |
Chondrocostal joint sprain |
| Sprain of other site of shoulder and upper arm |
Sprain of upper extremity |
| Sprain of other specified site of elbow and forearm |
Sprain of upper extremity |
| Sprain of other specified site of sacroiliac region (disorder) |
Sprain of sacroiliac region |
| Sprain of septal cartilage of nose (disorder) |
Injury of nasal septum |
| Sprain tendon of finger |
Strain of finger tendon (disorder) |
| Sprain ulnar carpal complex nonspecific |
Sprain of ulnar carpal complex ligament (disorder) |
| Sprain volar radiocarpal ligament nonspecific |
Sprain of palmar radiocarpal ligament |
| Sprain wrist extensors |
Strain of wrist extensor tendon (disorder) |
| Sprain wrist flexors |
Strain of wrist flexor tendon |
| Sprain, biceps tendon |
Strain of tendon of biceps brachii (disorder) |
| Sprain, extensor digitorum tendon |
Strain of extensor digitorum tendon |
| Sprain, extensor pollicis longus tendon |
Strain of extensor pollicis longus tendon (disorder) |
| Sprain, extensor tendon, foot |
Strain of foot extensor tendon |
| Sprain, flexor digitorum profundus tendon |
Strain of flexor digitorum profundus tendon (disorder) |
| Sprain, flexor digitorum superficialis tendon |
Strain of flexor digitorum superficialis tendon |
| Sprain, flexor pollicis longus tendon |
Strain of flexor pollicis longus tendon |
| Sprain, flexor tendon, foot |
Strain of foot flexor tendon (disorder) |
| Sprain, plantaris tendon |
Strain of plantaris tendon |
| Sprain, triceps tendon |
Strain of tendon of triceps brachii (disorder) |
| Spreo superbus |
Lamprotornis superbus (organism) |
| Squamous carcinoma in situ - category (morphologic abnormality) |
Squamous cell carcinoma in situ (morphologic abnormality) |
| Squamous cell carcinoma - category (morphologic abnormality) |
Squamous cell carcinoma of primary, secondary, or uncertain origin |
| Squamous cell carcinoma in situ, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Squamous cell carcinoma (morphologic abnormality) |
| Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Squamous cell carcinoma (morphologic abnormality) |
| Squamous intraepithelial neoplasia - category (morphologic abnormality) |
Squamous intraepithelial neoplasia |
| Squid - dietary |
Squid (substance) |
| Stage 0a |
American Joint Committee on Cancer stage 0a (qualifier value) |
| Stage 0is |
American Joint Committee on Cancer stage 0is (qualifier value) |
| Stage 1A |
IA |
| Stage 1A1 |
IA1 |
| Stage 1A2 |
IA2 |
| Stage 1B |
IB |
| Stage 1B1 |
IB1 |
| Stage 1B2 |
IB2 |
| Stage 1C |
IC |
| Stage 1S |
American Joint Committee on Cancer stage IS (qualifier value) |
| Stage 1a |
IA |
| Stage 1a1 |
IA1 |
| Stage 1a2 |
IA2 |
| Stage 1b |
IB |
| Stage 1c |
IC |
| Stage 2A |
American Joint Committee on Cancer stage IIA (qualifier value) |
| Stage 2B |
American Joint Committee on Cancer stage IIB (qualifier value) |
| Stage 2C |
IIC |
| Stage 2a |
American Joint Committee on Cancer stage IIA (qualifier value) |
| Stage 2b |
American Joint Committee on Cancer stage IIB (qualifier value) |
| Stage 2c |
IIC |
| Stage 3A |
American Joint Committee on Cancer stage IIIA (qualifier value) |
| Stage 3B |
American Joint Committee on Cancer stage IIIB (qualifier value) |
| Stage 3C |
American Joint Committee on Cancer stage IIIC (qualifier value) |
| Stage 3a |
American Joint Committee on Cancer stage IIIA (qualifier value) |
| Stage 3b |
American Joint Committee on Cancer stage IIIB (qualifier value) |
| Stage 3c |
American Joint Committee on Cancer stage IIIC (qualifier value) |
| Stage 4A |
American Joint Committee on Cancer stage IVA (qualifier value) |
| Stage 4B |
IVB |
| Stage 4C |
American Joint Committee on Cancer stage IVC (qualifier value) |
| Stage IVa |
American Joint Committee on Cancer stage IVA (qualifier value) |
| Stage IVb |
IVB |
FHIR